Keywords: sanofi-synthelabo/b-ms, plavix, under, fire, following, news, bristol-myers

Sanofi-Synthelabo/B-MS' Plavix under fire

Article | 25 April 2000

Following the news that Bristol-Myers Squibb is pulling its New DrugApplication for Vanlev (omapatrilat; see page 18), the company's cardiovascular franchise ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Clopidogrel

Plavix

Aspirin

Bayer

Go to drug listing